SLC2A1 and cancer: GLUT1 upregulation has been observed in cancers such as pancreatic cancer (Li et al., 2023), gastric cancer (Huber and DeRoche, 2023), lung cancer (Zhang et al., 2019), ovarian cancer (Rudlowski et al., 2004), cervical cancer (Rudlowski et al., 2003), and kidney cancer.